What is the Estimated CAGR of the Anatomic Pathology Market in Coming Years?
According to the United Nations Department of Economic and Social Affairs (UNDESA), the global population of people aged 65 years or above will increase from 727 million in 2020 to more than 1.5 billion by 2050. As age weakens the immune system, the elderly population is highly prone to chronic diseases such as cancer, cardiovascular diseases (CVDs), dementia, diabetes, organ failure, and chronic obstructive pulmonary disease (COPD), which can be diagnosed by using anatomic pathology. Thus, the surging population of the elderly will amplify the need for anatomic pathology tests in the foreseeable future. Additionally, the rising burden of chronic ailments, such as kidney diseases, cancer, autoimmune diseases, liver cirrhosis, hypertension, and heart diseases, especially in high and low- and middle-income countries (LMICs) will propel the anatomic pathology market at 5.8% CAGR during 2019–2024. According to P&S Intelligence, the market revenue will grow from $17.4 billion in 2018 to...